Differential Effects of Selective Inhibitors Targeting the PI3K/AKT/mTOR Pathway in Acute Lymphoblastic Leukemia

PURPOSE: Aberrant PI3K/AKT/mTOR signaling has been linked to oncogenesis and therapy resistance in various malignancies including leukemias. In Philadelphia chromosome (Ph) positive leukemias, activation of PI3K by dysregulated BCR-ABL tyrosine kinase (TK) contributes to the pathogenesis and develop...

Descripción completa

Detalles Bibliográficos
Autores principales: Badura, Susanne, Tesanovic, Tamara, Pfeifer, Heike, Wystub, Sylvia, Nijmeijer, Bart A., Liebermann, Marcus, Falkenburg, J. H. Frederik, Ruthardt, Martin, Ottmann, Oliver G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828226/
https://www.ncbi.nlm.nih.gov/pubmed/24244612
http://dx.doi.org/10.1371/journal.pone.0080070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828226/
https://www.ncbi.nlm.nih.gov/pubmed/24244612
http://dx.doi.org/10.1371/journal.pone.0080070

Ejemplares similares